新闻稿

Illumina to Announce Fourth Quarter and Fiscal Year 2015 Financial Results on Tuesday, February 2, 2016

SAN DIEGO--(BUSINESS WIRE)--Jan. 19, 2016-- Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for fourth quarter and fiscal year 2015 following the close of market on Tuesday, February 2, 2016.

On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time), Jay Flatley, Chief Executive Officer; Francis deSouza, President; and Marc Stapley, Executive Vice President, Chief Administrative Officer, and Chief Financial Officer, will host a conference call with analysts, investors, and other interested parties to discuss financial and operating results.

Conference Call Details

The conference call will begin at 2:00 pm Pacific Time (5:00 pm Eastern Time) on Tuesday, February 2, 2016. Interested parties may listen to the call by dialing 888.687.3295 (passcode: 21551023), or if outside North America by dialing +1.503.406.4070 (passcode: 21551023). Individuals may access the live teleconference in the Investor Relations section of Illumina’s web site under the “company” tab at www.illumina.com.

A replay of the conference call will be available from 5:00 pm Pacific Time (8:00 pm Eastern Time) on February 2, 2016 through February 9, 2016 by dialing 855.859.2056 (passcode: 21551023), or if outside North America by dialing +1.800.585.8367 (passcode: 21551023).

About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and follow @illumina.

Source: Illumina, Inc.

Illumina, Inc.
Investors:
Rebecca Chambers, 858.255.5243
rchambers@illumina.com
or
Media:
Eric Endicott, 858.882.6822
pr@illumina.com

近期文章

基因检测改写了她的抗癌之路也重塑了她的家族谱系
基因检测改写了她的抗癌之路也重塑了她的家族谱系
扎根中国二十载,因美纳加速精准医疗新篇章
扎根中国二十载,因美纳加速精准医疗新篇章
解码基因组,共抗抗菌药物耐药性
解码基因组,共抗抗菌药物耐药性